Fennec Pharmaceuticals Inc (FENC) Live Share Price, Invest From India

Fennec Pharmaceuticals Inc Stock Performance

as on April 14, 2026 at 6:59 am IST

Day's Low
Day's High
$5.65
Day's Price Range
$6.14
$5.92
4.56%
Downside
3.72%
Upside
52 Week's Low
52 Week's High
$4.98
52-Week Price Range
$9.92
$5.92
15.88%
Downside
67.57%
Upside

Fennec Pharmaceuticals Inc share price movements today

Previous Close: $5.81
Open: $5.80
Volume: 251.6K
Day's Low - High: $5.65 - $6.14
52 Week Low - High: $4.98 - $9.92

Fennec Pharmaceuticals Inc Historical Returns

1 Month Return: -21.14 %
3 Month Return: -21.77 %
1 Year Return: + 12.52 %
3 Year Return: -29.57 %
5 Year Return: -8.06 %

Fennec Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Fennec Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$200.3M

EPS (TTM)

0.2183

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

1.4678

EBITDA

-6.2M

Revenue (TTM)

44.6M

Profit Margin

-21.82%

Return On Equity TTM

-65.82%

Fennec Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fennec Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Fennec Pharmaceuticals Inc	BUY	$200.3M	-8.06%	NA	-21.82%
Alnylam Pharmaceuticals Inc	BUY	$42.7B	140.76%	138.84	8.45%
Vertex Pharmaceuticals Inc	BUY	$111.0B	102.67%	28.5	32.94%
BeiGene, Ltd.	NA	$35.6B	NA	124.86	5.37%
Regeneron Pharmaceuticals Inc	BUY	$79.2B	55.14%	18.05	31.41%

Stock Returns calculator for Fennec Pharmaceuticals Inc Stock including INR - Dollar returns

The Fennec Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Fennec Pharmaceuticals Inc investment value today

Current value as on today

₹1,21,849

Returns

₹21,849

(+21.85%)

Returns from Fennec Pharmaceuticals Inc Stock

₹12,334 (+12.33%)

Dollar Impact

₹9,515 (+9.51%)

Analyst Recommendation on Fennec Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Fennec Pharmaceuticals Inc. Average target price of $15.17

Fennec Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Fennec Pharmaceuticals Inc.

What analysts predicted

60.98%UPSIDE

Target Price

$15.17

Current Price

$5.92

Analyzed by

12 Analysts

Target

$15.17

Fennec Pharmaceuticals Inc target price $15.17, a slight upside of 60.98% compared to current price of $5.92. According to 12 analysts rating.

Fennec Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Fennec Pharmaceuticals Inc Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: March 15, 2026 to April 14, 2026

Change:-17% versus previous 30 day period

Fennec Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	6	10	25	7	6	7	8	9	12	13
Gross Profit	6	9	24	6	5	7	8	8	11	12
Operating Income	-1	-1	13	-5	-5	0	0	-2	0	-3
EBITDA	0	-1	14	-4	-4	0	0	-2	0	-3
Interest Expense	0	0	1	1	1	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-1	-2	12	-5	-5	-1	-1	-3	0	-5
Income Tax Expense	0	0	0	0	-	0	-	-	-	-
Net Income	-1	-2	12	-5	-5	-1	-1	-3	0	-5
Net Profit Margin	-28.66%	-27.55%	50.59%	-76.47%	-82.23%	-25.05%	-13.31%	-32.66%	-5.12%	-37.34%

Fennec Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	0	0	1	21	47	45
Gross Profit	-	-	-	-	0	-	1	19	44	41
Operating Income	-2	-6	-10	-13	-17	-17	-21	-12	2	-6
EBITDA	0	0	0	-12	-17	-17	-21	-12	4	-6
Interest Expense	-	-	-	-	0	0	0	3	4	2
Depreciation	-	-	-	0	0	0	0	0	0	0
Income Before Tax	-2	-7	-9	-12	-18	-17	-22	-16	0	-10
Income Tax Expense	0	0	0	0	0	0	1	0	0	-
Net Income	-2	-7	-9	-12	-18	-17	-22	-16	0	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-10652.35%	-10113.75%	-1544.89%	-75.50%	-0.92%	-22.62%

Fennec Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	12	-5	-5	-1	-1	-3	0	-4
Operating Cash Flow	-4	39	-8	-2	-1	-4	-3	1	-5
Investing Cash Flow	-	-	-	0	0	-	-	-	-
Financing Cash Flow	5	-1	0	0	-12	0	0	1	20
Change in Cash	0	37	-8	-2	-13	-3	-3	3	14

Fennec Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-9	-12	-18	-17	-23	-16	0	-10
Operating Cash Flow	-3	-7	-9	-15	-14	-18	-17	26	-12
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	27	2	0	32	4	20	6	-13	22
Change in Cash	24	-5	-9	16	-9	2	-10	13	10

Global Institutional Holdings in Fennec Pharmaceuticals Inc

Funds	Holdings
Solas Capital Management LLC	7.43%
Vanguard Group Inc	3.1%
State Street Corp	0.99%
The Informed Momentum Company (formerly EAM Investors)	0.28%
Citadel Advisors Llc	0.58%

See all

Insights on Fennec Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 34.2% return, outperforming this stock by 24.0%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 58.0% return, outperforming this stock by 89.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, FENC stock has moved down by -8.1%

About Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Organisation	Fennec Pharmaceuticals Inc
Headquarters	68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
Industry	Biotechnology
CEO	Mr. Jeffrey S. Hackman
E-voting on shares	Click here to vote

Key Management of Fennec Pharmaceuticals Inc

Name	Title
Mr. Jeffrey S. Hackman	CEO & Director
Mr. Robert C. Andrade	Chief Financial Officer
Dr. Pierre S. Sayad M.S., Ph.D.	Chief Medical Officer
Mr. Terry Evans	Chief Commercial Officer
Ms. Christiana Cioffi M.B.A.	Chief Strategy Officer
Mr. Mark Gowland	Controller
Mr. Lei Fang	President of Pharstat Inc

FAQs

What is Fennec Pharmaceuticals Inc share price today?

Fennec Pharmaceuticals Inc share price today is $5.92 as on April 14, 2026 at 1:29 am IST at the close of the market. Fennec Pharmaceuticals Inc share today touched a day high of $6.14 and a low of $5.65.

What is the 52 week high and 52 week low for Fennec Pharmaceuticals Inc share?

Fennec Pharmaceuticals Inc share touched a 52 week high of $9.92 on October 6, 2025 and a 52 week low of $4.98 on April 14, 2025. Fennec Pharmaceuticals Inc stock price today i.e. April 14, 2026 at 1:29 am IST is closed at $5.92,which is 40.32% down from its 52 week high and 18.88% up from its 52 week low.

What is Fennec Pharmaceuticals Inc's market capitalisation today?

Fennec Pharmaceuticals Inc market capitalisation is $0.00T as on April 14, 2026 at 1:29 am IST.

How to invest in Fennec Pharmaceuticals Inc Stock (FENC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Fennec Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fennec Pharmaceuticals Inc Shares that will get you 0.2534 shares as per Fennec Pharmaceuticals Inc share price of $5.92 per share as on April 14, 2026 at 1:29 am IST.

What is the minimum amount required to buy Fennec Pharmaceuticals Inc Stock (FENC) from India?

Indian investors can start investing in Fennec Pharmaceuticals Inc (FENC) shares with as little as ₹93.337 or $1 (as of April 14, 2026 at 9:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹933.37 in Fennec Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on April 14, 2026 at 9:41 am IST). Based on Fennec Pharmaceuticals Inc share’s latest price of $5.92 as on April 14, 2026 at 1:29 am IST, you will get 1.6892 shares of Fennec Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Fennec Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Fennec Pharmaceuticals Inc stock has given -8.06% share price returns and 23.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?